Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis
- 1 July 1985
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 124 (1) , 61-66
- https://doi.org/10.1002/jcp.1041240111
Abstract
We investigated the effects of the iron chelator desferrioxamine on the expression of transferrin receptors (TfR) by CCRF‐CEM human T‐cell leukaemia and B16 mouse melanoma cells growing in tissue culture. Desferrioxamine (DFOA) enhanced TfR expression when added in the dosse range of 10−5−10−4 to CCRF‐CEM cells, but was toxic to these cells, the lower concentrations producing a slowing of cell growth with a build up in S‐phase, while higher concentrations caused cell death with a block at the G1/S‐phase interface. These toxic effects are compatible with its previously reported inhibition of teh non‐haen iron containing (M2) subunit of ribonucleotide reductase. In marked contrast, DFOA caused the growth of B16 melanoma cells to arrest in G1, without loss of cloning efficiency, and resulted in a fall in TfR expression to approximately 50% of control values. These results suggested that the effects of DFOA on TfR expression were linked to DNA synthesis rather than to a more generalised inhibition of iron‐depdendent cellular processes. It was subsequently found that inhibition of the M2 subunit of ribonucloetide reductase in CCRF‐CEM cells with 5 x 10−5 M hydroxyurea, which is not an iron chelator, also enhanced TfR expression, as did thymidine and Cytosine arabinoside, which have different enzyme targets. By measuring cellular DNA and RNA content simultaneously it was shown that all of these agents caused unbalanced growth, i.e., inhibited DNA synthesis more than RNA synthesis. In contrast, 6‐thioguanine was more inhibitory to RNA synthesis, and treatment with this drug caused a fall in TfR expression. Thus, although CCRF‐CEM cells treated with DFOA show enhanced TfR expression, similar effects are also seen with other inhibitors of DNA synthesis, provided thatRNA synthesis is allowed to continue. These results provide further evidence that the regulation of TfR expression by proliferating cells is specifically linked to DNA synthesis rather than to the iron requirements of other cellular processes.This publication has 26 references indexed in Scilit:
- Transferrin receptor expression during exponential and plateau phase growth of human tumour cells in cultureJournal of Cellular Physiology, 1984
- Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide.Journal of Clinical Investigation, 1983
- Enzymic modification of a tyrosine residue to a stable free radical in ribonucleotide reductase.Proceedings of the National Academy of Sciences, 1983
- Effect of iron-chelating agents on inhibitors of ribonucleotide reductaseBiochemical Pharmacology, 1981
- FMFPAK1: A program package for routine analysis of single parameter flow microfluorimetric data on a low cost mini-computerComputers and Biomedical Research, 1980
- Modulation of cell surface iron transferrin receptors by cellular density and state of activationJournal of Supramolecular Structure, 1979
- Control of growth by picolinic acid: Differential response of normal and transformed cellsProceedings of the National Academy of Sciences, 1977
- Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human CellsBritish Journal of Haematology, 1976
- Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemiaCancer, 1965
- THE PLASMA-TO-CELL CYCLE OF TRANSFERRIN*Journal of Clinical Investigation, 1963